Angrist, M. & Gershon, S. (1970). The phenomenology of experimentally induced amphetamine psychosis – preliminary observations. Biological Psychiatry 2, 95–107.
Angrist, B., Lee, H. K. & Gershon, S. (1974). The antagonism of amphetamine-induced symptomatology by a neuroleptic. American Journal of Psychiatry 131, 817–819.
Bell, D. S. (1965). Comparison of amphetamine psychosis and schizophrenia. American Journal of Psychiatry 111, 701–707.
Bell, D. S. (1973). The experimental reproduction of amphetamine psychosis. Archives of General Psychiatry 29, 35–40.
Bowers, M. (1968). Pathogenesis of acute schizophrenic psychosis. Archives of General Psychiatry 19, 348.
Connell, P. (1958). Amphetamine Psychosis. Maudsley Monographs No. 5. Oxford University Press: London.
Eison, M., Eison, A. S. & Ellison, G. (1981). The regional distribution of d-amphetamine and local glucose utilization in rat brain during continuous amphetamine administration. Experimental Brain Research 43, 281–288.
Ellinwood, E. H. Jr (1967). Amphetamine psychosis: I. Description of the individuals and process. Journal of Nervous and Mental Disease 144, 273–283.
Ellinwood, E. H. Jr (1968). Amphetamine psychosis: II. Theoretical implications. Journal of Neuropsychiatry 4, 45–54.
Ellinwood, E. H. Jr & Kilbey, M. (1977). Chronic stimulant intoxication models of psychosis. In Animal Models in Psychiatry and Neurology (ed. Hanin, I. and Usdin, E.), pp. 61–74. Pergamon Press: Oxford.
Ellison, G. (1983). Phasic alterations in dopamine metabolites following continuous administration of amphetamines. Brain Research 268, 387–389.
Ellison, G. & Morris, W. (1981). Opposed stages of continuous amphetamine administration: Parallel alterations in motor stereotypies and in vivo spiroperidol binding. European Journal of Pharmacology 74, 207–214.
Ellison, G. & Ratan, R. (1982). The late stage following continuous amphetamine administration to rats is correlated with altered dopamine but not serotonin metabolism. Life Sciences 31, 771–777.
Ellison, G., Eison, M. & Huberman, H. (1978 a). Stages of constant amphetamine intoxication: Delayed appearance of abnormal social behaviors in rat colonies. Psychopharmacology 56, 293–299.
Ellison, G., Eison, M., Huberman, H. & Daniel, F. (1978 b). Structural and biochemical alterations in dopaminergic innervation of the caudate nucleus following continuous amphetamine administration. Science 201, 276–278.
Ellison, G., Nielsen, E. B. & Lyon, M. (1981). Animal model of psychosis: Hallucinatory behaviors in monkeys during the late stage of continuous amphetamine intoxication. Journal of Psychiatric Research 16, 13–22.
Fuller, R. & Hemrick-Luecke, S. (1980). Long-lasting depletion of striatal dopamine by a single injection of amphetamine in iprindole-treated rats. Science 209, 305–306.
Gold, M. S. & Bowers, M. Jr (1978). Neurobiological vulnerability to low-dose amphetamine psychosis. American Journal of Psychiatry 135, 1546–1548.
Griffith, J. D., Cavanaugh, J., Held, J. & Oates, J. (1972). Dextroamphetamines: Evaluation of psychomimetric properties in man. Archives of General Psychiatry 26, 97–100.
Hollister, L. E. (1968). Chemical Psychoses: LSD and Related Drugs. C. C. Thomas: Springfield, Ill.
Hotchkiss, A. & Gibb, J. (1980). Long-term effects of multiple doses of methamphetamine on tryptophan hydroxylase and tyrosine hydroxylase activity in rat brain. Journal of Pharmacology and Experimental Therapeutics 214, 257–262.
Howlett, D. R. & Nahorski, S. R. (1979). Acute and chronic amphetamine treatments modulate striatal dopamine receptor binding sites. Brain Research 161, 173–178.
Huberman, H. S., Eison, M. S., Bryan, K. S. & Ellison, G. (1977). A slow-release pellet for chronic amphetamine administration. European Journal of Pharmacology 45, 237.
Jacobs, B. L., Trulson, M.E. & Stern, W. C. (1976). An animal model for studying the actions of LSD and related hallucinogens. Science 194, 741–743.
Klawans, H. L. & Margolin, D. I. (1975). Amphetamine-induced dopaminergic hypersensitivity in guinea pigs. Archives of General Psychiatry 32, 725–732.
Kramer, J. C. (1969). Introduction to amphetamine abuse. Journal of Psychedelic Drugs 2, 8–13.
Kramer, J. C., Gischman, V. & Littlefield, D. (1967). Amphetamine abuse: Pattern and effects of high doses taken intravenously. Journal of the American Medical Association 201, 89–93.
Levine, M.Hull, C., Garcia-Rill, E.Erinoff, E., Buchwald, N. & Heller, A. (1980). Long-term decreases in spontaneous firing of caudate neurons induced by amphetamine in cats. Brain Research 194, 263–268.
Lyon, M. & Nielsen, E. (1979). Drug induced stereotypies and psychosis. In Psychopathology in Animals (ed. Keehn, J.), pp. 103–142. Academic Press: New York.
Nelson, L. & Ellison, G. (1978). Enhanced stereotypies after repeated injections but not continuous amphetamines. Neuropharmacology 17, 1081–1084.
Nielsen, E., Lee, T. & Ellison, G. (1980 a). Following several days of continuous administration d-amphetamine acquires hallucinogen-like properties. Psychopharmacology 68, 197–200.
Nielsen, E. B., Nielsen, M., Ellison, G. & Braestrup, C. (1980 b). Decreased spiroperidol and LSD binding in rat brain after continuous amphetamine. European Journal of Pharmacology 66,149–154.
Nwanze, E. & Jonsson, G. (1981). Amphetamine neurotoxicity on dopamine nerve terminals in the caudate nucleus of mice. Neuroscience Letters 26, 163–168.
Randrup, A. & Munkvad, I. (1974). Pharmacology and physiology of stereotyped behaviour. Journal of Psychiatric Research 11, 1–10.
Ricaurte, G. A., Schuster, C. R. & Seiden, L. S. (1980). Long-term effects of repeated methylamphetamine administration on dopamine and serotonin neurons in the rat brain: A regional study. Brain Research 193, 153–163.
Ridley, R., Baker, H., Owen, F., Cross, A. & Crow, T. (1982). Behavioral and biochemical effects of chronic amphetamine treatment in the vervet monkey. Psychopharmacology 78, 245–251.
Schlemmer, R. F., Thompson, V. D. & Davis, J. M. (1977). Effect of hallucinogen, 5-methoxy-N, N-dimethyltryptamine on primate social behaviour. Communications in Psychopharmacology 1,105–118.
Segal, D. S. & Mandell, A. J. (1974). Long-term administration of d-amphetamine: progressive augmentation of motor activity and stereotypy. Pharmacology, Biochemistry and Behavior 2, 255–259.
Slater, E. (1959). Amphetamine psychosis. British Medical Journal i, 488.
Smith, R. C. (1969). The world of the Haight–Ashbury speed freak. Journal of Psychedelic Drugs 2, 77–83.
Snyder, S. H., Bannerjee, S., Yamamura, H. & Greenberg, D. (1974). Drugs, neurotransmitters, and schizophrenia: phenothiazines, amphetamine, and enzymes synthesizing psychotomimetic drugs aid schizophrenia research. Science 184, 1243–1253.
Steranka, L. & Sanders-Bush, E. (1980). Long-term effects of continuous exposure to amphetamine on brain dopamine concentration and synaptosomal uptake in mice. European Journal of Pharmacology 65, 439–443.
Stevens, J. R. (1973). An anatomy of schizophrenia? Archives of General Psychiatry 29, 177–189.
Templeton, G. & Spruiell, V. (1958). Methedrine interviews: clinical and Rorschach studies. Psychiatric Quarterly 32, 781–795.
Trulson, M. & Jacobs, B. (1981). Long-term amphetamine treatment decreases brain serotonin metabolism: implications for theories of schizophrenia. Science 205, 1295–1297.
Wyatt, R. (1978). Is there an endogenous amphetamine? A testable hypothesis of schizophrenia. In The Nature of Schizophrenia (ed. Wynne, L., Cromwell, R. and Matthysse, S.), pp. 116–125. Wiley & Sons: New York.
Young, D. & Scoville, W. B. (1938). Paranoid psychosis in narcolepsy and the possible danger of Benzedrine treatment. Medical Clinics of North America 22, 637–646.
